This result might pave a way for the IL-22 therapy in experimental studies and clinical trials of PCOS, while a new clinical study observed no differences in the circulating concentrations of IL-22 and IL-22BP between PCOS individuals and healthy controls [100]. The gene discussed is IL22; the disease is polycystic ovary syndrome.